The Vocal Biomarker market is the industry that develops and distributes technological solutions for analysing speech patterns and their relationship to different medical and psychiatric problems. The human voice contains a plethora of information that may be analysed and interpreted to provide information about a person’s health, emotional state, and cognitive performance. Vocal biomarker technology captures and analyses speech data in order to uncover biomarkers that may signal the existence of certain illnesses.
The worldwide vocal biomarker market is presently worth $2.3 billion and is expected to grow to $9.5 billion by the end of 2033. Over the next 10 years, global demand for voice biomarkers is expected to grow at a CAGR of 14.7%. The market for vocal biomarkers is predicted to expand due to expanding demand for non-invasive and cost-effective diagnostic techniques, the rising incidence of chronic illnesses, and the potential of vocal biomarkers to enhance disease diagnosis and monitoring accuracy. However, legal constraints, privacy issues, and the need for more comprehensive clinical validation may pose challenges to the industry.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=719
Which Factors Could Audibly Promulgate Vocal Biomarker Demand?
- Increasing prevalence of chronic diseases: The rising incidence of chronic diseases such as depression, anxiety, Parkinson’s disease, and Alzheimer’s disease is expected to drive the demand for vocal biomarker technology, as it offers a non-invasive and cost-effective way to diagnose and monitor these conditions.
- Advancements in voice analysis technology: Advancements in voice analysis technology, such as machine learning and artificial intelligence, are expected to enhance the accuracy and reliability of vocal biomarker technology, further increasing its demand.
- Growing focus on preventive healthcare: The increasing focus on preventive healthcare is expected to drive the demand for vocal biomarker technology, as it can identify early signs of disease and enable timely intervention.
- Need for remote monitoring: With the growing popularity of telehealth and remote monitoring, vocal biomarker technology can be used to remotely monitor a patient’s health status, reducing the need for in-person visits and enhancing patient convenience.
- Potential to improve patient outcomes: The potential of vocal biomarker technology to improve patient outcomes by providing more objective and quantifiable data is expected to drive demand in the healthcare industry
Key Takeaways from Market Study
- Rising prevalence of chronic diseases: The increasing prevalence of chronic diseases such as depression, anxiety, and Parkinson’s disease is driving the demand for non-invasive and cost-effective diagnostic tools such as vocal biomarker technology.
- Non-invasive and cost-effective: Vocal biomarker technology offers a non-invasive and cost-effective way to diagnose and monitor various medical and psychological conditions.
- Potential for accuracy improvement: Vocal biomarkers have the potential to improve the accuracy of disease diagnosis and monitoring by providing more objective and quantifiable data.
- Key players and investments: The vocal biomarker market is highly competitive, with key players such as Beyond Verbal Communication, Sonde Health Inc., Cogito Corporation, and IBM Corporation investing in research and development to improve the accuracy and reliability of vocal biomarker technology.
- Regulatory barriers and privacy concerns: The vocal biomarker market may face challenges such as regulatory barriers and privacy concerns, which may limit its adoption in certain regions and applications
Competitive Landscape
Top vocal biomarker suppliers are concentrating on creating and releasing new products that aid them in maximizing the use of vocal biomarkers for various use cases.
- Sonde Health unveiled a mental health monitoring system in October 2021 that assesses a person’s mental health using a voice sample. As an application programming interface (API), the Sonde Mental Fitness technology was accessible to wellness service providers, healthcare systems, and employers.
Key Companies Profiled
- Boston Technology Corporation
- EVOCAL Health
- Audio Profiling
- Cogito Corporation
- Kintsugi
- Sharecare Inc.
- Microtest Health
- Sonde Health
- AudEERING
- Beyond Verbal
- IBM Corporation
Key Segments of Vocal Biomarker Industry Research
- By Technique :
- Frequency
- Amplitude
- Error Rate
- Vocal Rise or Fall Time
- Phonation Time
- Voice Tremor
- Pitch
- Others
- By Indication :
- Psychiatric Disorders
- Respiratory Disorders
- Cardiovascular Disorders
- Traumatic Brain Injury (TBI)
- Neurological Disorders
- Other Disorders
- By End User :
- Hospitals & Clinics
- Contract Research Organizations (CROs)
- Academic & Research Centers
- Other End Users
- By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Overall, the vocal biomarker market has significant growth potential, driven by the increasing demand for non-invasive and cost-effective diagnostic tools and the potential for vocal biomarkers to improve the accuracy of disease diagnosis and monitoring
